STING1 and urothelial neoplasm: The prevalence of STING positivity was intermediate for urothelial neoplasms (51.3–79.6%), adenocarcinoma of the esophagus (57.4%), and several important sarcoma categories such as liposarcoma (50.9%) and osteosarcoma (48.3%).